Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

1,292 results
Display

A Case of Acquired Acrodermatitis Enteropathica Caused by Zinc Deficiency in a Hepatocellular Carcinoma Patient

Lee YY, Kim SM, Choi MS, Hong D, Lee Y, Seo YJ, Jung KE

  • KMID: 2532852
  • Korean J Dermatol.
  • 2022 Aug;60(7):455-457.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Virtual reality education program including three-dimensional individualized liver model and education videos: A pilot case report in a patient with hepatocellular carcinoma

Rhu J, Lim S, Kang D, Cho J, Lee H, Choi GS, Kim JM, Joh JW

Three-dimensional (3D) modeling of the liver can be especially useful for both the surgeon and patient to understand the actual location of the tumor and planning the resection plane. Virtual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999–2019

Hong SY, Kang MJ, Kim T, Jung KW, Kim BW

Backgrounds/Aims: Historically, incidence and survival analysis and annual traits for primary liver cancer (LC) has not been investigated in a population-based study in Korea. The purpose of the current study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgery

Utsumi M, Inagaki M, Kitada K, Tokunaga N, Kondo M, Sakurai Y, Yunoki K, Hamano R, Miyasou H, Tsunemitsu Y, Otsuka S

Purpose: This study was performed to determine the prognostic value of lymphocyte-to-CRP ratio after curative resection for hepatocellular carcinoma. Methods: Between July 2010 and October 2021, 173 consecutive patients (144 male,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting

Tan CH, Chou Sc, Inmutto N, Ma K, Sheng R, Shi Y, Zhou Z, Yamada A, Tateishi R

Gadoxetate magnetic resonance imaging (MRI) is widely used in clinical practice for liver imaging. For optimal use, we must understand both its advantages and limitations. This article is the outcome...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4

Liu Y, Zhang X, Chen S, Wang J, Yu S, Li Y, Xu M, Aboubacar H, Li J, Shan T, Wang J, Cao G

Background/Aims: Binge drinking leads to many disorders, including alcoholic hepatosteatosis, which is characterized by intrahepatic neutrophil infiltration and increases the risk of hepatocellular carcinoma (HCC). Molecular mechanisms may involve the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

Iwamoto H, Shimose S, Niizeki T, Koga H, Torimura T, The Kurume Liver Cancer Study Group of Japan

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma

Kwak MH, Lee MW, Ko SE, Rhim H, Kang TW, Song KD, Kim JM, Choi GS

Purpose: Radiofrequency ablation is a curative treatment option for very early-stage or earlystage hepatocellular carcinoma (HCC). However, percutaneous radiofrequency ablation (PRFA) for subphrenic tumors is technically challenging. Laparoscopic radiofrequency ablation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance

Komuta M

Treatment of intrahepatic cholangiocarcinoma (iCCA) is currently at a significant turning point due to the identification of isocitrate dehydrogenase (IDH) mutations and fibroblast growth factor receptor (FGFR) fusions that can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?

Goh MJ, Sinn DH

Preclinical studies highlighted potential therapeutic applications of aspirin and statins as anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the role of aspirin and statins in the chemoprevention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound

Park J, Lee JM, Kim TH, Yoon JH

Hepatocellular carcinoma (HCC) is a unique cancer entity that can be noninvasively diagnosed using imaging modalities without pathologic confirmation. In 2018, several major guidelines for HCC were updated to include...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined?

Kang HJ, Kim JH, Yoo J, Han JK

Purpose: The aim of this study was to investigate the optimal washout criteria of perfluorobutane-enhanced ultrasonography (PFB-US) for the diagnosis of hepatocellular carcinoma (HCC) in high-risk individuals. Methods: Participants at risk...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection

Yu JH, Cho SG, Jin YJ, Lee JW

Chronic hepatitis B (CHB) seriously threatens human health. About 820,000 deaths annually are due to related complications such as hepatitis B and hepatocellular carcinoma (HCC). Recently, the use of oral...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance

Yun JH, Baek MJ, Jung HI

Purpose: Recently, microRNA (miRNA) has been evaluated to provide a new diagnostic and therapeutic modality hepatocellular carcinoma (HCC) and other tumors. They are small non-coding RNA molecules that function as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance

Park HJ, Seo N, Kim SY

While ultrasound (US) is considered an important tool for hepatocellular carcinoma (HCC) surveillance, it has limited sensitivity for detecting early-stage HCC. Abbreviated MRI (AMRI) has recently gained popularity owing to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching

Ko SE, Lee MW, Ahn S, Rhim H, Kang TW, Song KD, Kim JM, Choi GS, Cha DI, Min JH, Sinn DH, Choi MS, Lim HK

Objective: To compare the therapeutic outcomes of laparoscopic hepatic resection (LHR) and laparoscopic radiofrequency ablation (LRFA) for single subcapsular hepatocellular carcinoma (HCC). Materials and Methods: We screened 244 consecutive patients who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pure laparoscopic versus open left lateral sectionectomy for hepatocellular carcinoma: A propensity score matching analysis

Bae SJ, Cho HD, Kim KH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Lee SG

Backgrounds/Aims: Anatomical resection has superior oncologic outcomes over non-anatomical resection in hepatocellular carcinoma, and left lateral sectionectomy is the simplest and easiest perform anatomical resection procedure among liver resections. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of the Liver Imaging Reporting and Data System on Research Studies of Diagnosing Hepatocellular Carcinoma Using MRI

Ahn Y, Choi SH, Jang JK, Kim SY, Shim JH, Lee SS, Byun JH

Objective: Since its introduction in 2011, the CT/MRI diagnostic Liver Imaging Reporting and Data System (LI-RADS) has been updated in 2014, 2017, and 2018. We evaluated the impact of CT/MRI...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation

Hwang HS, Yoo JE, Han DH, Choi JS, Lee JG, Joo DJ, Kim MS, Kim SI, Choi GH, Park YN

Background/aims: Circulating tumor cells (CTCs) with cancer stemness have been demonstrated to be a direct cause of tumor recurrence, and only few studies have reported the role of CTCs in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of tumor size on hepatectomy outcomes in hepatocellular carcinoma: a nationwide propensity score matching analysis

Hong SK, Lee KW, Lee S, Hong Sy, Suh S, Han ES, Choi Y, Yi NJ, Suh KS

Purpose: The aim of this study was to compare surgical outcomes after liver resection for hepatocellular carcinoma (HCC) according to tumor size using a large, nationwide cancer registry-based cohort and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr